Literature DB >> 26843220

Metastatic small bowel neuroendocrine tumour with bilateral carcinoid heart disease.

V Jahagirdar1, Ali Kamal1, R Steeds2, John Ayuk3.   

Abstract

A 63-year-old woman was admitted with a year's history of exertional breathlessness, anxiety attacks, syncopal episodes, diarrhoea, fatigue, reduced appetite, 2 stones weight loss, and flushing affecting her face and trunk. Investigations revealed raised urine 5-hydroxy indole acetic acid (5-HIAA) and chromogranin A. CT scan demonstrated extensive soft tissue encasing the major vessels intra-abdominally, and a retroperitoneal mass. (111)In-octreotide single-photon emission CT (SPECT CT) showed increased focal activity in the mediastinum, retroperitoneum and mesenteric lymph nodes. Para aortic lymph node biopsy confirmed the diagnosis of metastatic well-differentiated grade 1 gastrointestinal neuroendocrine tumour (NET). Extensive cardiac investigations confirmed severe mitral regurgitation, moderate aortic and tricuspid regurgitation, and mild pulmonary regurgitation. The patient's symptoms of flushing and diarrhoea were controlled with octreotide LAR, and she underwent mechanical aortic and mitral valve replacement. Following discharge from surgery, she went on to develop hydronephrosis and urosepsis, followed by infective endocarditis, resulting in recurrent admissions, and eventually passed away in her sleep nearly 14 months after her initial diagnosis. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26843220      PMCID: PMC4746514          DOI: 10.1136/bcr-2015-213693

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century.

Authors:  Sanjeev Bhattacharyya; Christos Toumpanakis; Martyn Evan Caplin; Joseph Davar
Journal:  Am J Cardiol       Date:  2007-12-21       Impact factor: 2.778

2.  Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease.

Authors:  Sanjeev Bhattacharyya; Christos Toumpanakis; Martyn Evan Caplin; Joseph Davar
Journal:  Am J Cardiol       Date:  2008-07-17       Impact factor: 2.778

3.  Carcinoid syndrome from small bowel endocrine carcinoma in the absence of hepatic metastasis.

Authors:  Sayan Datta; Nigel Williams; Sari Suortamo; Asif Mahmood; Colin Oliver; Nicholas Hedley; Pijush Ray
Journal:  Age Ageing       Date:  2011-09-07       Impact factor: 10.668

Review 4.  Prognosis of patients with carcinoid heart disease after valvular surgery.

Authors:  Imthiaz Manoly; Sarah-Louise McAnelly; Sanjeevan Sriskandarajah; Kenneth Edward McLaughlin
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-05-08

5.  CTGF, intestinal stellate cells and carcinoid fibrogenesis.

Authors:  M Kidd; I M Modlin; M D Shapiro; R L Camp; S M Mane; W Usinger; J R Murren
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

Review 6.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 7.  Fibrosis and carcinoid syndrome: from causation to future therapy.

Authors:  Maralyn Druce; Andrea Rockall; Ashley B Grossman
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

8.  Carcinoid syndrome from gastrointestinal carcinoids without liver metastasis.

Authors:  J M Feldman; R S Jones
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

9.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Authors:  John K Ramage; A Ahmed; J Ardill; N Bax; D J Breen; M E Caplin; P Corrie; J Davar; A H Davies; V Lewington; T Meyer; J Newell-Price; G Poston; N Reed; A Rockall; W Steward; R V Thakker; C Toubanakis; J Valle; C Verbeke; A B Grossman
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

10.  Trends of incidence and survival of gastrointestinal neuroendocrine tumors in the United States: a seer analysis.

Authors:  Vassiliki L Tsikitis; Betsy C Wertheim; Marlon A Guerrero
Journal:  J Cancer       Date:  2012-07-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.